Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
How Malonic Acid Could Change Starch Mechanics
2026-11-16
Malonic acid, or propanedioic acid, has a chemically plausible role in starch-network modification because its two carboxyl groups can potentially interact with hydroxyl-rich polymer chains. That molecular possibility does not by itself establish mechanical property enhancement; the relevant evidence must connect chemical structure to network architecture and measured material behavior.
What 5-HT2 Signaling Can Tell Us About Seizures
2026-11-15
Ro 60-0175 fumarate is best interpreted as a receptor-to-network research probe. Its documented 5-HT2 receptor agonism provides a framework for studying how serotonergic signaling may influence neural excitability, while a zebrafish Dravet syndrome context remains model-level evidence rather than proof of antiepileptic efficacy.
What TRPV1 Antagonism Can—and Cannot—Show
2026-11-14
SB705498 illustrates how evidence can progress from receptor-level TRPV1 blockade to animal pain models and human itch challenges, while also showing why target engagement does not automatically predict symptom relief.
IRP2, TFEB, and Macrophage Antimicrobial Defense
2026-11-13
Published mouse, cellular, and human-tissue findings connect IRP2 loss with impaired lysosomal function, defective macrophage bacterial clearance, and liver abscess susceptibility after intestinal barrier injury. The evidence supports a macrophage-centered mechanism involving HIF2α, lactate, and TFEB, while leaving cell-type specificity and clinical causality unresolved.
What p53 mRNA–LNP Evidence Shows
2026-11-13
A 2025 review supports lipid nanoparticles as a plausible carrier platform for nucleic-acid cancer therapies, but p53 mRNA evidence remains mainly preclinical, context-dependent, and insufficient to establish product-specific or clinical efficacy.
How Azido-PEG6-alcohol Connects Molecular Handles
2026-11-12
Azido-PEG6-alcohol is best understood as a PEG-based linker whose azide group enables two conceptually distinct click-chemistry pathways. The documented chemistry supports interpretation of its molecular connectivity, but not conclusions about conversion, stability, biological performance, or any particular conjugate.
What High-Fidelity PCR Can Show in Nanomedicine
2026-11-12
A mechanistic reading of a calcium-lactate bufalin–CRISPR nanomedicine study, separating PCR measurement fidelity from evidence for delivery, cell death, gene editing, immune remodeling, and antitumor activity.
How Citrulline Shapes Pathway Readouts
2026-11-11
Citrulline is best interpreted as a pathway intermediate rather than a standalone marker of one biological outcome. Its meaning depends on whether a measurement reflects urea-cycle conversion, arginine regeneration, nitric-oxide metabolism, or simple abundance in a particular biological compartment.
When Fluorescence Changes a Repair Result
2026-11-11
A fluorescent signal, an interaction map, and a cellular rescue experiment answer different scientific questions. In replication-stressed cells, the meaning of a result depends on whether the readout reports molecular presence, proximity, assembly, or function.
How Condensate Coronas Enable Biomolecule Transfer
2026-11-10
A mechanistic interpretation of how rare nanoparticle–condensate hybrids acquire, protect and transfer proteins and RNAs, with emphasis on causal evidence, measurement limits and applicability.
How Condensate Coronas Move RNA Between Cells
2026-11-10
A Nature Materials study describes rare nanoparticle–cell hybrids that acquire biomolecular condensates, are re-exported, and deliver intact proteins and RNAs to recipient-cell compartments. Its strongest contribution is mechanistic: the condensate appears to regulate endosomal release and intracellular access, although event frequency, particle-to-particle heterogeneity, and broader biological applicability remain uncertain.
What Rare Particle Complexes Actually Show
2026-11-09
A recent study describes rare nanoparticle–condensate hybrids that can carry proteins and RNA between cells. Its strongest evidence concerns particle composition, intracellular trafficking and reporter activity; broader claims about physiological relevance, generality and delivery performance remain unresolved.
Condensate Coronas and Intercellular RNA Transfer
2026-11-09
A Nature Materials study describes rare nanoparticle–condensate hybrids that acquire cell-derived proteins and RNAs, are re-exported, and deliver cargo to other cells. The evidence supports a mechanistic model for privileged intracellular access, while leaving the prevalence, cargo heterogeneity, and broader applicability of the process unresolved.
NHE1, Calcium, and Macrophage Atherosclerosis
2026-11-08
A mouse and macrophage study supports a mechanistic link between octanal/Olfr2 signaling, NHE1 dysregulation, calcium- and ROS-associated responses, and atherosclerotic lesion severity. The evidence is directionally consistent across tissue, cellular, pharmacological, and genetic measurements, but the precise ordering of calcium signaling, NHE1 activation, and inflammasome engagement remains unresolved.
How Condensate Coronas Transfer RNA Between Cells
2026-11-07
A Nature Materials study describes rare hybrid nanoparticle complexes that acquire cell-derived biomolecular condensates, are re-exported, and deliver intact proteins and RNAs to recipient cells. The findings clarify how intracellular processing, condensate composition, and endosomal interactions may govern access to the cytosol and nucleus, while leaving important questions about prevalence and generality unresolved.